Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy

Form 483 issued April 5, 2019 · Bristol, Tennessee

Inspection
Mar 26 – Apr 5, 2019
Investigators
June P. Page· Xiaohui Shen
Observations
4
Pages
6
FEI number
3014877770

In short: On April 5, 2019, FDA issued a Form 483 with 4 observations to Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy in Bristol, Tennessee (FEI 3014877770) after an inspection that ran Mar 26 – Apr 5, 2019. The investigators were June P. Page and Xiaohui Shen.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 501(a)(2)(A)

    The ISO 5 classified aseptic processing areas had difficult to clean and visibly…

  2. 02
    FDCA 501(a)(2)(A)

    Non-microbial contamination was observed…

  3. 03
    FDCA 501(a)(2)(A)

    Unsealed, loose ceiling tiles were…

  4. 04
    FDCA 501(a)(2)(A)

    You produced hazardous chugs without providing adequate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy?

FDA listed 4 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy?

June P. Page and Xiaohui Shen are named on this Form 483, for the inspection of Mar 26 – Apr 5, 2019. Each investigator has a profile showing what they cite most.

When was Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy inspected by FDA?

The inspection ran Mar 26 – Apr 5, 2019, and the Form 483 is dated April 5, 2019.

How do I get the full Form 483 for Anderson Compounding Pharmacy, Inc. dba Anderson Compounding Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free